Drugs / CINHYALURONATE SODIUM
CINHYALURONATE SODIUM
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01558999 | Mar → Jul 2012 | dry eye syndrome | Seikagaku Corporation | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02205840 | Jul → Nov 2014 | dry eye syndrome | Seikagaku Corporation | Completed | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT05411367 | Jul 2022 → Mar 2023 | dry eye syndrome | Seikagaku Corporation | Completed | Missed primary |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2022-05-13 | Seikagaku Corporation | Seikagaku Initiates a Phase III Clinical Study for SI-614, a Therapeutic Agent for Dry Eye, in the U.S. seikagaku.co.jp ↗ |
| 2014-05-07 | Seikagaku Corporation | Seikagaku Initiates a Phase II/III Clinical Trial for SI-614, Indicated for Treatment of Dry Eye, in the U.S. seikagaku.co.jp ↗ |
| 2012-01-23 | Seikagaku Corporation | Seikagaku Initiates a Phase II Clinical Trial in the United States for SI-614, Indicated for Treatment of Dry Eye seikagaku.co.jp ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CINHYALURONATE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298103 ↗ |
| Known as | Cinhialuronato de sodio | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298103 ↗ |
| Known as | Cinhyaluronate de sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298103 ↗ |
| Known as | SI-614 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01558999 ↗ |
| Known as | SODIUM SALT OF HYALURONIC ACID PARTLY (12%) AMIDIFIED WITH 3-((3-PHENYLPROP-2-ENOYL)OXY)PROPAN-1-AMINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298103 ↗ |